GSK is accused of trying to suppress editorial on rosiglitazone.
Tanne
Janice Hopkins
JH
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D004345:Drug Industry / Q000941:ethics*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D010506:Periodicals as Topic / Q000941:ethics; D011643:Publishing / Q000941:ethics*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D014342:Truth Disclosure / Q000941:ethics*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone